Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
mTOR inhibition prevents angiotensin II–induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice
Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides
Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides
View: Text | PDF
Research Article Vascular biology

mTOR inhibition prevents angiotensin II–induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice

  • Text
  • PDF
Abstract

Aortic dissection and rupture are triggered by decreased vascular wall strength and/or increased mechanical loads. We investigated the role of mTOR signaling in aortopathy using a well-described model of angiotensin II–induced dissection, aneurysm, or rupture of the suprarenal abdominal aorta in Apoe-deficient mice. Although not widely appreciated, nonlethal hemorrhagic lesions present as pseudoaneurysms without significant dissection in this model. Angiotensin II–induced aortic tears result in free rupture, contained rupture with subadventitial hematoma (forming pseudoaneurysms), dilatation, or healing, while the media invariably thickens regardless of mural tears. Medial thickening results from smooth muscle cell hypertrophy and extracellular matrix accumulation, including matricellular proteins. Angiotensin II activates mTOR signaling in vascular wall cells, and inhibition of mTOR signaling by rapamycin prevents aortic rupture but promotes dissection. Decreased aortic rupture correlates with decreased inflammation and metalloproteinase expression, whereas extensive dissection correlates with induction of matricellular proteins that modulate adhesion of vascular cells. Thus, mTOR activation in vascular wall cells determines whether aortic tears progress to dissection or rupture. Previous mechanistic studies of aortic aneurysm and dissection by angiotensin II in Apoe-deficient mice should be reinterpreted as clinically relevant to pseudoaneurysms, and mTOR inhibition for aortic disease should be explored with caution.

Authors

Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides

×

Figure 4

Medial thickening results from SMC hypertrophy and ECM accumulation.

Options: View larger image (or click on image) Download as PowerPoint
Medial thickening results from SMC hypertrophy and ECM accumulation.
Apo...
Apoe–/– mice were infused with saline or AngII and the suprarenal abdominal aortas were analyzed after 0–7 days. (A) Immunofluorescence microscopy for SMA expression (green) with DAPI-labeled nuclei (blue) at day 7, scale bar: 50 μm. (B) Number of SMCs per cross section (x‑sec) extrapolated from counts of medial nuclei after 7 days (n = 8). (C) Flow cytometry for forward (FSC-A) and side (SSC‑A) scatter area of enzymatically isolated SMA+ SMCs at 0, 1, and 7 days (n = 8). (D) Immunostains for F4/80+ cells in intima (I), media (M), adventitia (A), and perivascular tissue (P) at 7 days, scale bar: 50 μm. (E) Number of F4/80+ macrophages (M) in vascular wall layers at 7 days (n = 5–7). (F) Quantitative RT-PCR for selected transcripts regulating ECM synthesis and degradation, namely Col1a1, Col3a1, Spp1 (encoding osteopontin), Mmp2, Mmp3, Mmp14, Thbs1, Tnc, and Ccn2 (encoding CTGF) at 0, 1, and 7 days (n = 4). (G) Expression of thrombospondin-1 (TSP1), tenascin-C (TNC), and CTGF (green) with DAPI-labeled nuclei (blue) at 7 days, scale bars: 50 μm. Individual data shown, bars represent mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, unpaired, 2-tailed t test (B), 1‑way ANOVA with Tukey’s multiple-comparison test (C and F), and 2-way ANOVA with Sidak’s multiple-comparison test (E).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts